Healthcare Plans — industry outlook

• Period: 2026-09-16 to 2026-10-07
• Events: 1
• Generated: 2026-10-07T06:30:00.003Z

Medicaid Rate Dynamics and Enrollment Attrition

Centene (CNC) targets a 5% composite Medicaid rate growth for 2026, predicting rates will rise to maintain budget neutrality as enrollment declines by 8% to 9% in 2026 due to redeterminations. Management anticipates that 25% to 40% of expansion business members may become ineligible over the 2027–2028 cycle. While states face budget pressures driving 40%+ of fee-for-service Medicaid dollars into managed care, Centene expects the 2026 membership decline to roll into subsequent years, with remaining members undergoing a gradual, monthly eligibility verification cadence in 2027 and 2028. The primary risk is that rates may not perfectly or timely match the increased acuity of the remaining population in 2027.

Medicare Advantage Margin Trajectory and Portfolio Strategy

Centene (CNC) expects Medicare Advantage (MA) margins to perform well in 2026, targeting a break-even or better baseline in 2027 with continued progression thereafter. The company is executing a simplification strategy for 2027 to exit non-core geographies, focusing exclusively on dual and complex populations where it maintains a competitive footprint. While raw quality measures are improving despite "Stars Club" constraints, Centene advocates for better case-mix adjustments for duals. Management expects no immediate financial impact from CMS Star score reform before 2030–2031.

Part D and ACA Margin Expectations

Centene (CNC) guides for 4.5% to 5% pre-tax ACA margins in 2026, having fully accounted for program integrity efforts and enrollment attrition. For Part D, the company targets >3% margins, having achieved benchmark status in all 34 regions for 2027; this outlook assumes no continuation of pandemic-era premium subsidies. In 2027, Part D revenue is positioned for strong growth due to a 27% increase in direct subsidies, supported by a cost structure that does not own a PBM.

Regulatory and Operational Headwinds

Centene (CNC) notes that fraud, waste, and abuse trends remain persistent, particularly in behavioral health and high-cost drugs, though aggressive utilization of AI tools has accelerated claim shutdown times. The company is monitoring 340B pricing and rebate yields to prevent gaming while ensuring program functionality for FQHCs. Specific market exits, such as a $1.5 billion quarterly revenue loss in Florida behavioral health, were driven by unsustainable contract terms rather than knee-jerk reactions. Management remains confident in navigating these headwinds through data-driven advocacy and rate management.